Sicong Wang - Publications

Affiliations: 
Peking University, Beijing, Beijing Shi, China 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Wang S, Lin CW, Carleton AE, Cortez CL, Johnson C, Taniguchi LE, Sekulovski N, Townshend RF, Basrur V, Nesvizhskii AI, Zou P, Fu J, Gumucio DL, Duncan MC, Taniguchi K. Spatially resolved cell polarity proteomics of a human epiblast model. Science Advances. 7. PMID 33893097 DOI: 10.1126/sciadv.abd8407  0.356
2019 Xu Y, Peng L, Wang S, Wang A, Ma R, Zhou Y, Yang J, Sun DE, Lin W, Chen X, Zou P. Corrigendum: Hybrid Indicators for Fast and Sensitive Voltage Imaging. Angewandte Chemie (International Ed. in English). 58: 15183. PMID 31609545 DOI: 10.1002/Anie.201910449  0.46
2019 Xu Y, Peng L, Wang S, Wang A, Ma R, Zhou Y, Yang J, Sun D, Lin W, Chen X, Zou P. Berichtigung: Hybrid Indicators for Fast and Sensitive Voltage Imaging Angewandte Chemie. 131: 15325-15325. DOI: 10.1002/Ange.201910449  0.46
2018 Xu Y, Peng L, Wang S, Wang A, Ma R, Zhou Y, Yang J, Sun DE, Lin W, Chen X, Zou P. Hybrid Indicators for Fast and Sensitive Voltage Imaging. Angewandte Chemie (International Ed. in English). PMID 29437274 DOI: 10.1002/Anie.201712614  0.454
2015 Feng Y, Liu L, Hu S, Zou P, Zhang J, Huang C, Wang Y, Wang S, Zhang X. Efficient fluorescence energy transfer system between fluorescein isothiocyanate and CdTe quantum dots for the detection of silver ions. Luminescence : the Journal of Biological and Chemical Luminescence. PMID 26277997 DOI: 10.1002/bio.2967  0.333
2013 Zhang T, Li Y, Zou P, Yu JY, McEachern D, Wang S, Sun D. Physiologically based pharmacokinetic and pharmacodynamic modeling of an antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in a mouse xenograft model of human breast cancer. Biopharmaceutics & Drug Disposition. 34: 348-59. PMID 23813446 DOI: 10.1002/Bdd.1850  0.361
2013 Zhao Y, Yu S, Sun W, Liu L, Lu J, McEachern D, Shargary S, Bernard D, Li X, Zhao T, Zou P, Sun D, Wang S. A potent small-molecule inhibitor of the MDM2-p53 interaction (MI-888) achieved complete and durable tumor regression in mice. Journal of Medicinal Chemistry. 56: 5553-61. PMID 23786219 DOI: 10.1021/Jm4005708  0.355
2012 Wang S, Yang R, Zou P, Hou M, Wu D, Shen Z, Lu X, Li Y, Chen X, Niu T, Sun H, Yu L, Wang Z, Zhang Y, Chang N, et al. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia. International Journal of Hematology. 96: 222-8. PMID 22753022 DOI: 10.1007/s12185-012-1124-8  0.32
2012 Zou P, Zheng N, Yu Y, Yu S, Sun W, McEachem D, Yang Y, Yu LX, Wang S, Sun D. Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokinetics. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, Sociã©Tã© Canadienne Des Sciences Pharmaceutiques. 15: 265-80. PMID 22579006 DOI: 10.18433/J34S4N  0.365
2011 Zheng N, Zou P, Wang S, Sun D. In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 627-35. PMID 21177985 DOI: 10.1124/Dmd.110.036418  0.332
2010 Zou P, Yu Y, Wang YA, Zhong Y, Welton A, Galbán C, Wang S, Sun D. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. Molecular Pharmaceutics. 7: 1974-84. PMID 20845930 DOI: 10.1021/Mp100273T  0.372
2010 Li J, Suo J, Zou P, Jia L, Wang S. Structure, corrosion behavior and mechanical property of a novel poly(vinyl alcohol) composite in simulated body fluid. Journal of Biomaterials Science. Polymer Edition. 21: 863-76. PMID 20482989 DOI: 10.1163/156856209X448084  0.337
Show low-probability matches.